Hiv-1 reporter viruses and their use in assaying anti-viral compounds

Details for Australian Patent Application No. 2001275357 (hide)

Owner Bristol-Myers Squibb Company

Inventors Spicer, Timothy P.; Blair, Wade

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2001275357

PCT Pub. Number WO01/96610

Priority 60210626 09.06.00 US

Filing date 7 June 2001

Wipo publication date 24 December 2001

Acceptance publication date 8 June 2006

International Classifications

C12N 15/867 (2006.01) Mutation or genetic engineering - Retroviral vectors

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

Event Publications

8 June 2006 Application Accepted

  Published as AU-B-2001275357

5 October 2006 Standard Patent Sealed

31 January 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001275358

2001275356